Tectonic Therapeutic Inc expected to post a loss of $1.09 a share - Earnings Preview

Tectonic Therapeutic

05/05/2025 22:18

Tectonic Therapeutic Inc TECX.OQ TECX.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Tectonic Therapeutic Inc is for a loss of $1.09 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Tectonic Therapeutic Inc is $72.50​, above​ its last closing price of $21.75. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-1.39
-0.84
Beat
39.4
Sep. 30 2024
-0.82
-0.82
-1.20
Missed
-45.5
Jun. 30 2024
-1.40
-1.50
-4.34
Missed
-189.3​
Mar. 31 2024
-4.32
-4.32
-1.80
Beat
58.3
​​Dec. 31 2023
-4.95
-4.04
-2.40
Beat
40.6
Sep. 30 2023
-3.34
-3.40
-5.28
Missed
-55.3​
Jun. 30 2023
-2.48
-0.90
-4.44
Missed
-395
Mar. 31 2023
-6.50
-6.54
-6.84
Missed
-4.6

This summary was machine generated May 5 at 21:18 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)